Anavex Life Sciences Corp. (AVXL) Statistics & Valuation Metrics - Stocknear

Anavex Life Sciences Corp...

NASDAQ: AVXL · Real-Time Price · USD
8.66
0.16 (1.88%)
At close: Sep 26, 2025, 3:59 PM
8.66
0.00%
After-hours: Sep 26, 2025, 06:47 PM EDT

Anavex Life Sciences Statistics

Share Statistics

Anavex Life Sciences has 85.89M shares outstanding. The number of shares has increased by 0.68% in one year.

85.89M
0.68%
0.36%
36.87%
83.01M
3,060
0.28%

Short Selling Information

The latest short interest is 24.84M, so 28.92% of the outstanding shares have been sold short.

24.84M
28.92%
29.9%
21.1

Valuation Ratios

The PE ratio is -11.03 and the forward PE ratio is 3.59. Anavex Life Sciences's PEG ratio is 0.83.

-11.03
3.59
0
2.2
3.94
-15.39
0.83
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Anavex Life Sciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.86, with a Debt / Equity ratio of 0.

8.86
8.86
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.02M
42
0
n/a

Taxes

-2.29M
5.33%

Stock Price Statistics

The stock price has increased by 52.46% in the last 52 weeks. The beta is 0.83, so Anavex Life Sciences's price volatility has been higher than the market average.

0.83
52.46%
10.06
9.41
41.82
1,087,834

Income Statement

n/a
n/a
-52.88M
-43M
-45.29M
-45.29M
-0.52
Full Income Statement

Balance Sheet

The company has 132.19M in cash and 0 in debt, giving a net cash position of 132.19M.

132.19M
n/a
n/a
-336.07M
102.43M
93.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.81M and capital expenditures 0, giving a free cash flow of -30.81M.

-30.81M
n/a
-30.81M
-0.37
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AVXL is $46, which is 431.2% higher than the current price. The consensus rating is "Buy".

$46
431.2%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Oct 7, 2015. It was a backward split with a ratio of 1:4.

Oct 7, 2015
backward
1:4

Scores

33.87
1